Found: 8
Select item for more details and to access through your institution.
The Ras Antagonist, Farnesylthiosalicylic Acid (FTS), Decreases Fibrosis and Improves Muscle Strength in dy<sup>2J</sup>/dy<sup>2J</sup> Mouse Model of Muscular Dystrophy.
- Published in:
- PLoS ONE, 2011, v. 6, n. 3, p. 1, doi. 10.1371/journal.pone.0018049
- By:
- Publication type:
- Article
H-Ras Nanocluster Stability Regulates the Magnitude of MAPK Signal Output.
- Published in:
- PLoS ONE, 2010, v. 5, n. 8, p. 1, doi. 10.1371/journal.pone.0011991
- By:
- Publication type:
- Article
Galectin-1 binds oncogenic H-Ras to mediate Ras membrane anchorage and cell transformation.
- Published in:
- Oncogene, 2001, v. 20, n. 51, p. 7486, doi. 10.1038/sj.onc.1204950
- By:
- Publication type:
- Article
Inhibition of Contact Sensitivity by Farnesylthiosalicylic Acid-Amide, a Potential Rap1 Inhibitor.
- Published in:
- Journal of Investigative Dermatology, 2011, v. 131, n. 10, p. 2040, doi. 10.1038/jid.2011.152
- By:
- Publication type:
- Article
Vitamin D and S-Farnesylthiosalicylic Acid Have a Synergistic Effect on Hepatic Stellate Cells Proliferation.
- Published in:
- Digestive Diseases & Sciences, 2014, v. 59, n. 10, p. 2462, doi. 10.1007/s10620-014-3207-2
- By:
- Publication type:
- Article
Prevention of Induced Colitis in Mice by the Ras Antagonist Farnesylthiosalicylic Acid.
- Published in:
- Digestive Diseases & Sciences, 2012, v. 57, n. 2, p. 320, doi. 10.1007/s10620-011-1880-y
- By:
- Publication type:
- Article
Orally administered FTS (salirasib) inhibits human pancreatic tumor growth in nude mice.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2008, v. 61, n. 1, p. 89, doi. 10.1007/s00280-007-0451-6
- By:
- Publication type:
- Article
Farnesylthiosalicylic acid (salirasib) inhibits Rheb in TSC2-null ELT3 cells: A potential treatment for lymphangioleiomyomatosis.
- Published in:
- International Journal of Cancer, 2012, v. 130, n. 6, p. 1420, doi. 10.1002/ijc.26139
- By:
- Publication type:
- Article